Cargando…
Using transcriptomics to identify and validate novel biomarkers of human skeletal muscle cancer cachexia
BACKGROUND: Cancer cachexia is a multi-organ tissue wasting syndrome that contributes to morbidity and mortality in many cancer patients. Skeletal muscle loss represents an established key feature yet there is no molecular understanding of the disease process. In fact, the postulated molecular regul...
Autores principales: | Stephens, Nathan A, Gallagher, Iain J, Rooyackers, Olav, Skipworth, Richard J, Tan, Ben H, Marstrand, Troels, Ross, James A, Guttridge, Denis C, Lundell, Lars, Fearon, Kenneth C, Timmons, James A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829926/ https://www.ncbi.nlm.nih.gov/pubmed/20193046 http://dx.doi.org/10.1186/gm122 |
Ejemplares similares
-
Evaluating potential biomarkers of cachexia and survival in skeletal muscle of upper gastrointestinal cancer patients
por: Stephens, Nathan A, et al.
Publicado: (2015) -
Intramyocellular lipid droplets increase with progression of cachexia in cancer patients
por: Stephens, Nathan A., et al.
Publicado: (2011) -
Clinical Classification of Cancer Cachexia: Phenotypic Correlates in Human Skeletal Muscle
por: Johns, Neil, et al.
Publicado: (2014) -
New genetic signatures associated with cancer cachexia as defined by low skeletal muscle index and weight loss
por: Johns, Neil, et al.
Publicado: (2016) -
Molecular studies of exercise, skeletal muscle, and ageing
por: Timmons, James A., et al.
Publicado: (2016)